Keywords: Chronic mitral regurgitation; Volume-overload left ventricular remodelling; Diabetes mellitus; Insuffisance mitrale chronique; Remodelage ventriculaire gauche induit par une surcharge en volume; Diabète; BMI; body mass index; DM; diabetes mellitus; LV; l
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AWT; Anterior wall thicknesses; BW; Body weight; CO; Cardiac output; DCM; Diabetic cardiomyopathy; DM; Diabetes mellitus; ECL; Enhanced chemiluminescence; EDP; End diastolic pressure; EF; Ejection fraction; HF; Heart failure; HR; Heart rate; HFD; High-fat
Keywords: PWT; posterior wall thickness; IVST; interventricular septum thickness; RWT; relative wall thickness; LVEDD; left ventricular end-diastolic diameter; LVESD; left ventricular end-systolic diameter; LV; left ventricular; SAP; systolic arterial pressure; DAP
Keywords: Cilostazol; Obesity; AngiotensinII; Diastolic dysfunction; HFpEF; TGF-β; PKM2; Ciloz; Cilostazol; AngII; AngiotensinII; HFD; High Fat Diet; FS; Fraction Shortening; EF; Ejection Fraction; HFpEF; Heart failure with Preserved Ejection Fraction; PKM2; Pyruv
Keywords: AB; aortic banding; PE; phenylephrine; ANP; atrial natriuretic peptide; ROS; reactive oxygen species; SOD1; superoxide dismutase 1; CAT; catalase; HO-1; heme oxygenase-1; MAPK; mitogen-activated protein kinase; ERK1/2; extracellular signal-regulated prote
Keywords: Acolor; Maximum area of the regurgitation jet; iSVR; Width of the left ventricular ejection tract regurgitation jet; LVeDD; Left ventricular end-diastolic diameter; LVeSD; Left ventricular end-systolic diameter; HR; Heart rate; ShFr; Shortening fraction;
Keywords: AI; aortic insufficiency; AVS; aortic valve sparing; Echo; echocardiography; FS; Florida sleeve; LVEF; left ventricular ejection fraction; LVEDD; left ventricular end-diastolic diameter; LVESD; left ventricular end-systolic diameter; MFS; Marfan syndrome;
Keywords: Coronary artery bypass; Ventricular dysfunction; Complications; Mortality; AKI; acute kidney injury; AUC; area under curve; BMI; body mass index; CABG; coronary artery bypass grafting; CAD; coronary artery disease; CI; confidence interval; COPD; chronic o
Keywords: Left atrial function; Left atrial function index; Cardiovascular diseases; Atrial fibrillation; Epidemiology; Echocardiography; CVD; Cardiovascular disease; LA; Left atrial; LAFI; Left atrial function index; LAmax; Maximum left atrial volume; LAmin; Minim
Keywords: Echocardiography; Fetal growth restriction; Hemodynamics; Pregnancy; Blood pressure; Cardiac function; A; peak velocity of the A wave; ABPM; ambulatory blood pressure monitoring; BMI; body mass index; BP; blood pressure; DBP; diastolic blood pressure; DTE
Keywords: Degenerative mitral regurgitation; Transcatheter mitral valve therapies; Minimally invasive mitral surgery; Outcomes; BNP; Brain natriuretic peptide; CMR; Cardiac magnetic resonance; DMR; Degenerative mitral regurgitation; EROA; Effective regurgitant orif
Keywords: A/C ratio; albumin/creatinine ratio; EF; ejection fraction; GLS; global longitudinal strain; GLSR; global longitudinal strain rate; GSRa; diastolic global strain rate during late diastole; GSRe; diastolic global strain rate during early diastole; GSRivr;
Keywords: CI; confidence interval; HF; heart failure; HR; hazard ratio; LA; left atrial; LBBB; left bundle branch block; LV; left ventricular; LVEDD; left ventricular end-diastolic diameter; LVEF; left ventricular ejection fraction; LVESD; left ventricular end-syst
Keywords: BAT; brown adipose tissue; UCP1; uncoupling protein 1; UCP1â/â; UCP1-deficient; LV; left ventricle; WT; wild-type; H/R; wall thickness/LV radius; LVMI; LV mass index; cTnI; cardiac troponin I; MI; myocardial infarct; LVEDD; LV end-diastolic diameter;
Keywords: AAC; amino acid coding; AF; atrial fibrillation; BMI; body mass index; ECG; electrocardiogram; ESP; Exome Sequencing Project; GWAS; genome-wide association study; IQR; interquartile range; LVEDD; left ventricular end-diastolic diameter; LVEF; left ventric
Keywords: AAD; antiarrhythmic drug; CAD; coronary artery disease; CCB; calcium channel blocker; DCM; dilated cardiomyopathy; ECG; electrocardiogram; ICM; ischemic cardiomyopathy; LV; left ventricular/ventricle; LVEDD; left ventricular end-diastolic dimension; LVEF;
Keywords: ACE; angiotensin I converting enzyme; AT1; angiotensin II type 1 receptor; CART; classification and regression tree; CAD; coronary artery disease; CHF; congestive heart failure; CVC; cross validation consistency; G-score; genotype score; LVD; left ventric
Keywords: decTime; deceleration time; EF; ejection fraction; IVRT; isovolumetric ventricular relaxation time; LAESV; left atrial end-systolic volume; LVEDD; left ventricular end diastolic diameter; LVEDV; left ventricular end diastolic volume; LVESD; left ventricul
Keywords: Kawasaki disease; Pulse-wave velocity; Vascular function; Echocardiography Doppler; AOcsa; Aortic annular cross-sectional area; AOd; End-diastolic aortic dimension; AOflow; Peak aortic flow; AOs; End-systolic aortic dimension; BPd; Diastolic blood pressur
Keywords: BrdU; thymidine analogue 5-bromo-29 deoxyuridine; CTx; cell transplantation; ECG; echocardiography; ELISA; enzyme-linked immunosorbent assay; LAD; left anterior descending artery; LE; laparotomy and abdominal aorta exposure; LVEDD; left ventricular end-di
Keywords: PLGA; poly(d,l-lactide-co-glycolide); IGF-1; insulin-like growth factor-1; NPs; nanoparticles; MI; myocardial infarction; QDs; quantum dots; EDC; 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide; LVEDd; left ventricular end-diastolic dimension; LVESd; left
Keywords: ATP; antitachycardia pacing; CI; confidence interval; CRT; cardiac resynchronization therapy; CRT-D; cardiac resynchronization therapy-defibrillator; HR; hazard ratio; LBBB; left bundle branch block; LV; left ventricular; LVEDD; left ventricular end diast
Keywords: Apoptosis; Cardiomyocyte; Coenzyme Q10; Diabetes; Diastolic function; Fibrosis; Hypertrophy; Inflammation; Superoxide; Free radicals; ACE-I; angiotensin-converting-enzyme inhibitor; ANP; atrial natriuretic peptide; AoSBP; aortic systolic blood pressure; B
Balance between angiogenic and anti-angiogenic isoforms of VEGF-A is associated with the complexity and severity of coronary artery disease
Keywords: CAD; coronary artery disease; SS; Syntax Score; VEGF-A; vascular endothelial growth factor-A; PCI; percutaneous coronary intervention; AP; angina pectoris; ACS; acute coronary syndrome; HD; hemodialysis; HbA1c; glycosylated hemoglobin; eGFR; estimated glo
A Tumor Necrosis Factor-α and Hypoxia-Induced Secretome Therapy for Myocardial Repair
Keywords: Ang; angiopoietin; BM-MSC; bone marrow mesenchymal stem cell; DAPI; 4,'6-diamidino-2-phenylindole; DMEM; Dulbecco's Modified Eagle's Medium; FGF; fibroblast growth factor; H9c2-CM; H9c2 cardiomyoblast-conditioned medium; LVEDD; left ventricular en
Pretreatment with an angiotensin II receptor blocker abolished ameliorating actions of adipose-derived stem cell sheets on cardiac dysfunction and remodeling after myocardial infarction
Keywords: Adipose-derived stem cell sheet; Myocardial infarction; Angiotensin II; Irbesartan; VEGF; ANP; atrial natriuretic peptide; ARB; angiotensin receptor blocker; ASC; adipose-derived stem cell; AT1(2)R; angiotensin II receptor type 1(2); CRT; cardiac resynchr
(Pro)renin receptor expression in myocardial infarction in transgenic mice expressing rat tonin
Keywords: AG; angiotensinogen; AG(1-14); angiotensinogen N-terminal tetradecapeptide; Ang I; angiotensin I; Ang II; angiotensin II; AT; atrium; ATR+L; atria; au; arbitrary units; C; control; CHF; congestive heart failure; EF; ejection fraction; FS; fractional sho
Cardiotonic actions of quercetin and its metabolite tamarixetin through a digitalis-like enhancement of Ca2+ transients
Keywords: Quercetin; Tamarixetin; Digitalis; Inotropic action; Cardiomyocyte; Ca2+ transient; bmp; beats per minute; CaT; Ca2+ transients; COMT; catechol-O-methyl transferase; cTnI; cardiac troponin I; cTnT; cardiac troponin T; DCM; dilated cardiomyopathy; DIG; dig
Protection of the myocardium against ischemia/reperfusion injury by angiotensin-(1-9) through an AT2R and Akt-dependent mechanism
Keywords: +dP/dt; maximum derivative of left ventricular pressure; ACE; angiotensin-converting enzyme; ACE2; angiotensin-converting enzyme 2; Akti; Akt inhibitor; AT2R; angiotensin type 2 receptor; CVD; cardiovascular diseases, EC50, effective concentration 50, I/R
Nanomedicine for the cardiac myocyte: Where are we?
Keywords: 7KC; 7-ketocholesterol; Ang II; Angiotensin II; AT1; Angiotensin II type 1; AT1R; Ang II type 1 receptor; Au; Gold; BIO; 6-Bromoindirubin-3 oxine.; CeO2; Cerium oxide/ceria; CLIO; Cross-linked iron oxide; CNF; Carbon nanofiber; CNT; Carbon nanotube; CsA;
G protein-coupled estrogen receptor (GPER) deficiency induces cardiac remodeling through oxidative stress
Keywords: 4-HNE; 4 hydroxynonenal; apoE; apolipoprotein E; AWTed; anterior wall thickness at end diastole; Ccl5; ligand 5; C-C motif; chemokine; CoQ10; ubiquinone; FS; fractional shortening; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; GPX; glutathione peroxida
Vitamin D levels and its supplementation in patients of heart failure
Keywords: Renin angiotensin aldosterone; Myocardial remodelling; Cholecalciferol; Radioimmunoassay; Echocardiography; Left ventricular; NYHA class; LVEF; LVESD; LVEDD; CAD; HHD; 7-dehydrocholesterol; Ultraviolet radiation;
Normative Left Ventricular M-Mode Echocardiographic Values in Preterm Infants up to 2 kg
Keywords: Echocardiography; Reference values; M-mode; Preterm; Left ventricle; BSA; Body surface area; ICC; Intraclass correlation coefficient; IVSd; End-diastolic interventricular septal thickness; LBM; Lean body mass; LMS; Lambda-mu-sigma; LV; Left ventricular; L
Clinical Implications of Three-Dimensional Real-Time Color Doppler Transthoracic Echocardiography in Quantifying Mitral Regurgitation: A Comparison with Conventional Two-Dimensional Methods
Keywords: Mitral regurgitation; Three-dimensional echocardiography; Full volume color Doppler echocardiography; Proximal isovelocity surface area; 2D; Two-dimensional; 3D; Three-dimensional; AF; Atrial fibrillation; ASE; American Society of Echocardiography; CMR; C
Postconditioning with Intralipid emulsion protects against reperfusion injury in post-infarct remodeled rat hearts by activation of ROS-Akt/Erk signaling
Keywords: ADP; adenosine diphosphate; Akt; protein kinase B; ANOVA; analysis of variance; ANP; atrial natriuretic peptide; ATP; adenosine triphosphate; BSA; bovine serum albumin; CAL; coronary artery ligation; COX; cytochrome c oxidase; CS; citrate synthase; DTNB;
shRNA interference of NLRP3 inflammasome alleviate ischemia reperfusion-induced myocardial damage through autophagy activation
Keywords: sh-NLRP3; Ischemia reperfusion; Myocardial damage; Autophagy; I/R; ischemia-reperfusion; SD; Sprague-Dawley; KO; knock out; NLRP3; nod-like receptor protein 3; IL; interleukin; TNF-α; tumor necrosis factor α; HE; Hematoxylin and Eosin; WT; wild type; TU
Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling
Keywords: Traf2; tumor necrosis factor receptor-associated factor 2; TAC; constriction of transverse aortic; GSK3β; AKT/glycogen synthase kinase 3β; LVESD; left ventricle end-systolic diameter; LVEDD; left ventricle end-diastolic diameter; PCR; polymerase chain r
2017 ESC/EACTS Guidelines for the management of valvular heart disease. Summary prepared by the Czech Society of Cardiology
Keywords: ÎPm; mean transvalvular pressure gradient; 2D; two-dimensional; 3D; three-dimensional; ABC; age, biomarkers, clinical history; ACE; angiotensin-converting enzyme; ACS; acute coronary syndrome; ARB; angiotensin receptor blocker; AVA; aortic valve area; BA
miR-322 regulates insulin signaling pathway and protects against metabolic syndrome-induced cardiac dysfunction in mice
Keywords: miR; microRNA; HFD; high fat diet; CD; control diet; IGF-1; insulin growth factor-1; IGF1R; insulin growth factor-1 receptor; INSR; insulin receptor; SIRT4; sirtuin 4; CD1; cyclin D1; VSMC; vascular smooth muscle cell; FS; fractional shortening; LVESD; le
Volume overload induces autophagic degradation of procollagen in cardiac fibroblasts
Keywords: VO; volume overload; MMP; matrix metalloproteinase; ACF; aortocaval fistula; DMNQ; 2,3-dimethoxy-1, 4-naphthoquinone; MR; mitral regurgitation; ECM; extracellular matrix; TGF; transforming growth factor; TNF; tumor necrosis factor; ER; endoplasmic reticul
Inhibition of MEF2A prevents hyperglycemia-induced extracellular matrix accumulation by blocking Akt and TGF-β1/Smad activation in cardiac fibroblasts
Keywords: MEF2A; myocyte enhancer factor 2A; CFs; cardiac fibroblasts; NG; normal glucose; HG; high glucose; OC; osmotic control; MAPK; mitogen-activated protein kinases; shRNAs; short-hairpin RNAs; RNAi; RNA interference; STZ; streptozotocin; MOI; multiplicity of
Paradoxically, iron overload does not potentiate doxorubicin-induced cardiotoxicity in vitro in cardiomyocytes and in vivo in mice
Keywords: ANP; atrial natriuretic peptide; AU; arbitrary unit; β-MHC; beta-myosin heavy chain; BNP; brain natriuretic peptide; cDNA; complementary deoxyribonucleic acid; DOX; doxorubicin; ECG; electrocardiogram; ESR; electron spin resonance; ET; ventricular ejecti
Cardiac-specific overexpression of catalase prevents diabetes-induced pathological changes by inhibiting NF-κB signaling activation in the heart
Keywords: CAT-TG; cardiac-specific catalase overexpression transgenic; WT; wild type; α-KGD; α-oxoglutarate dehydrogenase E1 component; KGDHC; α-ketoglutarate dehydrogenase complex; ATP-α; ATP synthase α subunit; ATP-β; ATP synthase β subunit; ROS; reactive
Protective effect of cilostazol against doxorubicin-induced cardiomyopathy in mice
Keywords: AMPK; AMP-activated protein kinase; BNP; B-type natriuretic peptide; Cilo; cilostazol; CTGF; connective tissue growth factor; DIC; Dox-induced cardiomyopathy; Dox; doxorubicin; HMGB1; high-mobility group box 1; HO-1; heme oxygenase 1; LVEDD; left ventricl
De Novo Aortic Regurgitation After Continuous-Flow Left Ventricular Assist Device Implantation
Keywords: ALT; alanine aminotransferase; AoV; aortic valve; AR; aortic regurgitation; BUN; blood urea nitrogen; cf-LVAD; continuous-flow left ventricular assist device; COPD; chronic obstructive pulmonary disease; CPB; cardiopulmonary bypass; CRP; C-reactive protei
Left ventricular dysfunction after mitral valve repair-the fallacy of “normal” preoperative myocardial function
Keywords: 35.4; 35.4.1; CI; confidence interval; EF; ejection fraction; HR; hazard ratio; LV; left ventricular; LVESD; LV end-systolic diameter; MR; mitral valve regurgitation; OR; odds ratio; RVSP; right ventricular systolic pressure;
2014 AHA/ACC guideline for the management of patients with valvular heart disease
Keywords: 2D; 2-dimensional; 3D; 3-dimensional; ACE; angiotensin-converting enzyme; AF; atrial fibrillation; ARB; angiotensin-receptor blocker; aPTT; activated partial thromboplastin time; AR; aortic regurgitation; AS; aortic stenosis; AVR; aortic valve replacement
Senescence marker protein 30 inhibits angiotensin II-induced cardiac hypertrophy and diastolic dysfunction
Keywords: SMP30; senescence marker protein 30; IVS; intraventricular septal thickness; PW; posterior wall thickness; LVEDD; left ventricular end-diastolic dimension; LVESD; left ventricular end-systolic dimension; FS; left ventricular fractional shortening; E; peak
The Development of Aortic Insufficiency in Continuous-Flow Left Ventricular Assist Device-Supported Patients
Keywords: AI; aortic insufficiency; AoV; aortic valve; BTT; bridge to transplantation; CI; confidence interval; DT; destination therapy; HM II; Heart Mate II; HR; hazards ratio; IABP; intraaortic balloon pump; LV; left ventricle; LVAD; left ventricular assist devic
One-Year Results After Implantation of the CorCap for Dilated Cardiomyopathy and Heart Failure
Keywords: CI; confidence interval; CRT; cardiac resynchronization therapy; HR; hazard ratio; LV; left ventricle; LVEDD; left ventricular end-diastolic diameter; LVEDV; left ventricular end-diastolic volume; LVEDVI; left ventricular end-diastolic volume index; LVEF;